GlassScriptPhysician profile
Rayan Saab
NPI 1720333867
$8,996.44
in general payments reported to CMS, 2019-2025
41 companies · $1,076 in 2025
The $1,076 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,700 · 2020: $976 · 2021: $1,570 · 2022: $2,315 · 2023: $546 · 2024: $813 · 2025: $1,076.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,435.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,489.79 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Abbott Laboratories | $1,166.58 | 2020-2025 | Xience Skypoint, Diamondback Coronary, Pressurewire |
| Abiomed | $1,071.81 | 2022-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $664.10 | 2019-2025 | Lifevest |
| Livanova USA, INC. | $405.52 | 2021-2022 | |
| Amgen INC. | $345.49 | 2020-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $266.45 | 2020-2023 | |
| E.R. Squibb & Sons, L.L.C. | $258.77 | 2020-2025 | Camzyos |
| Cardiovascular Systems INC. | $232.25 | 2019-2020 | |
| Amarin Pharma, INC. | $228.62 | 2019-2021 | |
| Shockwave Medical, INC | $225.29 | 2023-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Medtronic, INC. | $214.42 | 2022-2024 | Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $211.87 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $205.81 | 2019-2022 | |
| Philips North America LLC | $199.49 | 2019-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rayan Saab listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.